On the other hand, here we show that Verapamil has a beneficial effect in our AD models mostly by blocking TXNIP expression, and its effects are comparable with data obtained by silencing TXNIP in vitro and in vivo. This evidence concerns the gene TXNIP and Alzheimer disease.